Studies on the risk of breast cancer in correlation with the concentration of lipids in the bloodstream showed that mutations causing a decrease in PCSK-9 activity and, thus, a decrease in LDLc concentration, were associated with a lower risk of this type of cancer [71]. This evidence concerns the gene PCSK9 and breast carcinoma.